Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Arzneimittel-Forschung

• Publication date

  1995-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8929248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.

  1994cited by this paper
• [Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract].

  1993cited by this paper
• The immunomodulatory beta-galactoside-specific lectin from mistletoe: partial sequence analysis, cell and tissue binding, and impact on intracellular biosignalling of monocytic leukemia cells.

  1992cited by this paper
• Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients

  1992cited by this paper
• Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract.

  1990cited by this paper
• Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.

  1989cited by this paper

• The Anti-Inflammatory Activity of Viscum album

  2023cites this paper
• The use of mistletoe extracts in cancer patients

  2013cites this paper
• Mitogenic Response and Cytokine Production Induced by Cramoll 1,4 Lectin in Splenocytes of Inoculated Mice

  2011cites this paper
• Korean mistletoe lectin (KML-IIU) and its subchains induce nitric oxide (NO) production in murine macrophage cells.

  2008cites this paper
• Immune Modulation Using Mistletoe (Viscum album L.) Extracts Iscador

  2006cites this paper
• Einfluss eines ML-1-normierten Mistelextraktes auf die Lebensqualität bei Patienten mit Kopf-Hals-Karzinomen

  2006cites this paper
• [Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients].

  2006cites this paper
• Comparison of the Impact of Pro- and Antiinflammatory Immune Processes at the Two Immune-Deviated Sites, Eye and Solid Tumor and Possible Consequences for the Antitumoral Therapy with Fever Inducers

  2005cites this paper
• Complete structure determination of N‐acetyl‐D‐galactosamine‐binding mistletoe lectin‐3 from Viscum album L. album

  2005cites this paper
• Efficacy of Acupuncture for Treating Knee Osteoarthritis

  2005influential citation
• Phoradendron liga (Gill. ex H. et A.) Eichl. (Viscaceae) used in folk medicine: anatomical, phytochemical, and immunochemical studies.

  2004cites this paper
• Complete structure determination of the A chain of mistletoe lectin III from Viscum album L. ssp. album

  2004cites this paper
• Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.

  2003cites this paper
• Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA).

  2003cites this paper
• Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.

  2002cites this paper
• [Does mistletoe therapy influence the defense against epithelial tumors? A critical immunologic analysis].

  2001cites this paper
• Activated macrophages migrate to the subcutaneous tumor site via the peritoneum: a novel route of cell trafficking.

  2001cites this paper
• The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.

  2001cites this paper
• Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.

  2001cites this paper
• Beeinflusst die Misteltherapie die Abwehr epithelialer Tumoren? Eine kritische immunologische Analyse

  2001cites this paper
• El "muérdago criollo", Ligaria cuneifolia (R. et P.) Tiegh -Loranthaceae-. Desde el uso popular hacia el estudio de los eféctos farmacológicos

  2001cites this paper
• Modulation of Mistletoe (Viscum album L.) Lectins Cytotoxicity by Carbohydrates and Serum Glycoproteins

  2000cites this paper
• [Development of lymphocyte subsets in tumor patients after subcutaneous administration of mistletoe extracts].

  1999cites this paper
• Lymphocyte activation and cytokine production by Pisum sativum agglutinin (PSA) in vivo and in vitro.

  1999cites this paper
• SchluÈ sselwoÈ rter

  1999cites this paper
• Study of an Argentine mistletoe, the hemiparasite Ligaria cuneifolia (R. et P.) Tiegh. (Loranthaceae).

  1998cites this paper
• Anatomical, Phytochemical and Immunochemical Studies on Ligaria cuneifolia (R. et P.) Tiegh (Loranthaceae)

  1998cites this paper
• Effects of the Turkish subspecies of Viscum album on macrophage-derived cytokines.

  1998cites this paper
• Primary structure and molecular modeling of mistletoe lectin I from Viscum album.

  1998cites this paper
• Clinical relevance of immunoactive mistletoe lectin-l

  1997cites this paper
• Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice.

  1997cites this paper
• Chemische Standardisierung von Mistelextraktzubereitungen als Voraussetzung für den Nachweis der Wirksamkeit

  1996cites this paper